Skip to main content

ABI to Distribute Eksigent s Tempo Liquid Chromatography System

NEW YORK, Jan. 10 (GenomeWeb News) - Eksigent Technologies signed a distribution agreement with Applied Biosystems for a line of high performance liquid chromatography systems, the company said today.


Under the agreement, Eksigent will integrate its Microfluidic Flow Control technology with Applied Biosystems/MDS SCIEX mass spectrometers to create the Tempo liquid chromatography systems. The line includes platforms for nano LC, high-throughput micro LC and an LC-MALDI deposition system.


Applied Biosystems/MDS SCIEX will service and sell the resulting line as front ends to their mass spectrometers, Eksigent said.


Applied Biosystems/MDS SCIEX is a joint venture between ABI, an Applera business, and MDS SCIEX, a MDS division.


Additional details were not disclosed.


The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.